Inclusion body myositis: from genetics to clinical trials.

Nagy, Sara; Khan, Alaa; Machado, Pedro M; Houlden, Henry

Nagy, Sara; Khan, Alaa; Machado, Pedro M; Houlden, Henry.

Afiliação

Nagy S; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK. s.nagy@ucl.ac.uk.
Khan A; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland. s.nagy@ucl.ac.uk.
Machado PM; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK.
Houlden H; Molecular Diagnostic Unit, Clinical Laboratory Department, King Abdullah Medical City in Makkah, Mecca, Saudi Arabia.

J Neurol ; 270(3): 1787-1797, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36399165

Assuntos

Miosite de Corpos de Inclusão; Miosite; Humanos; Miosite de Corpos de Inclusão/genética; Miosite de Corpos de Inclusão/terapia; Progressão da Doença

Palavras-chave

Clinical trials; Gene therapy; Genetic susceptibility; Hereditary inclusion body myositis; Inflammation; Neurodegeneration; Sporadic inclusion body myositis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Miosite de Corpos de Inclusão / Miosite Limite: Humans Idioma: En Revista: J Neurol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google